Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer

Journal of Nuclear Medicine

Volumn 48, Issue 2, 2007, Pages 201-206

  Lerman, Hedva ^a   Lievshitz, Gennady ^a   Zak, Osnat ^b   Metser, Ur ^a,c   Schneebaum, Shlomo ^a,c   Even Sapir, Einat ^a,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b GE HEALTHCARE   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Breast; Cancer; Lymphoscintigraphy; Sentinel node; SPECT CT

Indexed keywords

DYE; RHENIUM TECHNETIUM TC 99M;

ACCURACY; ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; OBESITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BREAST TUMOR; IMAGE PROCESSING; LYMPH NODE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODES; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34047235833     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998;83:2776-2781.
2. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368-1377.
3. Chakera AH, Friis E, Hesse U, Al-Suliman N, Zerahn B, Hesse B. Factors of importance for scintigraphic non-visualization of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging. 2005;32:286-293.
4. Nos C, Freneaux P, Guilbert S, Falcou MC, Salmon RJ, Clough KB. Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification? Ann Surg Oncol. 2001;8:438-443.
5. Derossis AM, Fey JV, Cody HS III, Borgen PI. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg. 2003;197:896-901.
6. Even-Sapir E, Lerman H, Lievshitz G, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med. 2003;44:1413-1420.
7. Lerman H, Metser U, Lievshitz G, Sperber F, Schneebaum S, Even-Sapir E. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the roll of SPECT-CT. Eur J Nucl Med Mol Imaging. 2006;33:329-337.
8. Schneebaum S, Stadler J, Cohen M, Yaniv D, Baron J, Skornick Y. Gamma probe-guided sentinel node biopsy: optimal timing for injection. Eur J Surg Oncol. 1998;24:515-519.
9. Estourgie SH, Nieweg OE, Olmos RA, Rutgers EJ, Kroon BB. Lymphatic drainage patterns from the breast. Ann Surg. 2004;239:232-237.
10. Schneebaum S, Even-Sapir E, Lerman H, Gat A, Brazovsky E, Lievshitz G. Clinical application of gamma detection probes: radio guided surgery. Eur J Nucl Med. 1999;26(suppl):S26-S35.
11. Cox CE, Dupont E, Whitehead GF, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J. 2002;8:88-91.
12. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Can Med Assoc J. 1998;158(3 suppl):S22-S527.